scispace - formally typeset
T

Tilman B. Drüeke

Researcher at French Institute of Health and Medical Research

Publications -  415
Citations -  22817

Tilman B. Drüeke is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Kidney disease & Hyperparathyroidism. The author has an hindex of 68, co-authored 413 publications receiving 21471 citations. Previous affiliations of Tilman B. Drüeke include Versailles Saint-Quentin-en-Yvelines University & University of Paris-Sud.

Papers
More filters
Journal ArticleDOI

Nutritional status in dialysis patients: a European consensus

Francesco Locatelli, +6 more
- 01 Apr 2002 - 
TL;DR: The dietitian plays a pivotal role in the nutritional care of dialysis patients, and patients should be provided with dietary counselling from the start of substitutive treatment in order to meet the recommended nutritional intakes.
Journal ArticleDOI

AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients

Véronique Witko-Sarsat, +6 more
- 01 Jul 2003 - 
TL;DR: This dual potential of NAC to inhibit phagocyte oxidative responses induced by HSA-AOPP without affecting those mediated by compounds mimicking pathogens supports the proposal of a therapeutic trial with NAC aimed at reducing oxidative stress-related inflammation in hemodialysis patients.
Journal ArticleDOI

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Lucie Desjardins, +7 more
- 01 Jul 2012 - 
TL;DR: The data suggest that plasma FGF23 is an independent biomarker of vascular calcification in patients with various CKD stages including early stages, and it remains to be seen whether this association is independent of bone turnover and bone mass.
Journal ArticleDOI

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

Francesco Locatelli, +6 more
- 01 May 2002 - 
TL;DR: Achieving an evidence-based consensus can give clinicians a useful tool for the treatment of disturbances of Ca-P metabolism in CRI: this has become an important objective in nephrological care, particularly as ageing and increased risk of atherosclerosis have become major issues in the dialysis population.
Journal ArticleDOI

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

Stuart M. Sprague, +11 more
- 01 Apr 2016 - 
TL;DR: In this paper, the parathyroid hormone (PTH) concentration was used to discriminate low from nonlow and high from nonhigh BFR/BS, with an area under the receiver operating characteristic curve > 0.70 but not more than 323.0pg/mL.